Target (CBDY) Accumulated Expenses (2013 - 2020)

Target (CBDY) reported Accumulated Expenses of $1.2 million for Q1 2020, little changed quarter-over-quarter from $1.2 million in Q4 2019.

Target (CBDY) Accumulated Expenses (2013 - 2020) Analysis & Trends

Target (CBDY) has 5 years of Accumulated Expenses data on file, last reported at $1.2 million in Q1 2020.

  • Accumulated Expenses for Q1 2020 came in at $1.2 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2020 was $1.2 million (changed N/A YoY), and the FY2019 annual result was $1.2 million, changed N/A from the prior year.
  • Accumulated Expenses steadied at $1.2 million in Q1 2020 per CBDY's latest filing, from $1.2 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $1.2 million in Q4 2019 and troughed at $287291.0 in Q2 2018.
  • A 3-year average of $840717.8 and a median of $941860.0 in 2019 frame the typical range for Accumulated Expenses.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Target - - 191,787.00

Historic Data

Download Data
DateValue
Mar 31, 2020 1.19 Mn
Dec 31, 2019 1.19 Mn
Sep 30, 2019 691,860.00
Jun 30, 2018 287,291.00
Jun 30, 2014 1,150.00
Mar 31, 2014 1,150.00
Dec 31, 2013 400.00